Clinical trial · Observational
Interest and Impact of Skin Cancer Genetic Testing
PERSONALIZED GENOMIC TESTING FOR MELANOMA: MAXIMIZING COMPREHENSION AND HEALTH OUTCOMES IN SKIN CANCER PATIENTS
NCT02941900CI-TRIAL-00063344completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to learn whether the patient might be interested in skin cancer genetic testing, and if so, what kinds of thoughts, feelings, and behaviors might result from this testing. Testing for skin cancer risk based on the MC1R gene is not currently used in clinical practice; it will be offered in this study for research purposes only.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-melanoma Skin Cancer (NMSC) | Skin Carcinoma | ALIAS | 0.85 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Baseline Survey | Behavioral | — | UNRESOLVED |
| MC1R genotyping | Genetic | — | UNRESOLVED |
| MC1R Testing Website | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Non-melanoma skin cancers (NMSCs)
- interventionNames
- Genetic: MC1R genotyping
- Behavioral: MC1R Testing Website
- Behavioral: Baseline Survey
Primary outcomes (1)
- measure
- number of patients interested in MC1R testing
- timeFrame
- 1 year
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years of age or older * English fluent as we do not have the resources to translate all the materials including the website and risk feedback materials into other languages * Prior history of stage 0, I or II NMSC as per EMR or clinical judgment Exclusion Criteria: * Inability to provide meaningful informed consent due to cognitive or psychiatric disability as determined by the judgement of the consenting professional or clinician
References
Publications (0)
Data not yet available
No reference posted for this study.